Data / Form D filings / NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc.: Form D filings
NovaBay Pharmaceuticals, Inc., a company in Emeryville, CA, filed 19 Form D notices with the SEC between 2015 and 2026. The latest, on January 27, 2026, reports $134 million sold of a $134 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2000 POWELL STREET, SUITE 1150, Emeryville, CA, 94608
- Phone
- (510) 899-8800
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1389545
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | New notice | $134,000,000 | $134,000,000 | 4 | Jan 16, 2026 | sec.gov | |
| Jun 28, 2024 | New notice | $225,953 | $225,953 | 5 | Jun 14, 2024 | sec.gov | |
| Apr 5, 2024 | New notice | $665,000 | $665,000 | 5 | Mar 24, 2024 | sec.gov | |
| Jan 4, 2024 | New notice | $554,808 | $554,808 | 5 | Dec 21, 2023 | sec.gov | |
| May 18, 2023 | New notice | $3,000,000 | $3,000,000 | 5 | May 1, 2023 | sec.gov | |
| Sep 23, 2022 | New notice | $3,250,000 | $3,250,000 | 4 | Yet to occur | sec.gov | |
| Sep 23, 2022 | New notice | $2,065,500 | $2,065,500 | 9 | Sep 9, 2022 | sec.gov | |
| Nov 17, 2021 | New notice | $15,000,000 | $15,000,000 | 7 | Nov 2, 2021 | sec.gov | |
| Jul 31, 2020 | New notice | $6,829,580 | $0 | $6,829,580 | 0 | Jul 20, 2020 | sec.gov |
| May 22, 2020 | New notice | $1,731,030 | $1,030 | $1,730,000 | 0 | May 13, 2020 | sec.gov |
| May 1, 2020 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Aug 26, 2019 | New notice | $4,198,566 | $4,198,566 | 4 | Aug 13, 2019 | sec.gov | |
| Aug 26, 2019 | New notice | $2,700,000 | $2,700,000 | 3 | Aug 13, 2019 | sec.gov | |
| Jul 3, 2019 | New notice | $2,400,000 | $2,400,000 | 3 | Jun 26, 2019 | sec.gov | |
| Feb 14, 2018 | New notice | $5,984,000 | $5,984,000 | 1 | Feb 5, 2018 | sec.gov | |
| May 20, 2016 | New notice | $11,791,000 | $7,791,000 | $4,000,000 | 9 | May 9, 2016 | sec.gov |
| Feb 26, 2016 | New notice | $2,830,804 | $2,830,804 | 3 | Feb 16, 2016 | sec.gov | |
| Jun 4, 2015 | Amendment | $26,582,871 | $26,582,871 | 21 | Mar 6, 2015 | sec.gov | |
| Mar 19, 2015 | New notice | $15,134,300 | $15,134,300 | 14 | Mar 6, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael John Kazley | Executive Officer, Director | Chief Executive Officer |
Other companies in California that filed recently
- MoFlo Acquisitions, Inc. $587.5 million · Nov 2, 2026
- BC Movie, LLC offering · Nov 2, 2026
- Jana Education San Jose LLC $200,000 · Nov 2, 2026
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
Every Form D from the week of Jan 26, 2026 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what NovaBay Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.